BioCentury
ARTICLE | Company News

Juno Therapeutics, Celgene deal

January 18, 2016 8:00 AM UTC

Juno said it has an agreement in principle to grant Celgene a license to a subset of the technology Juno gained through its acquisition of AbVitro Inc. and options to gain rights to potential product...